GlassScriptPhysician profile
Archit A Naik
NPI 1730486184
$20,520.93
in general payments reported to CMS, 2019-2025
13 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $39.91 · 2021: $149 · 2022: $5,824 · 2023: $4,891 · 2024: $7,834 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,450 · Consulting Fee: $3,800 · Travel and Lodging: $1,969 · Food and Beverage: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,450.00 |
| Consulting Fee | $3,800.00 |
| Travel and Lodging | $1,969.11 |
| Food and Beverage | $880.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $19,494.29 | 2022-2025 | |
| Endomagnetics LTD | $182.06 | 2024 | Magseed, Magtrace |
| Stryker Corporation | $148.85 | 2019 | |
| Integra Lifesciences Corporation | $148.50 | 2021 | |
| Applied Medical Resources Corporation | $120.66 | 2025 | |
| Eisai INC. | $87.81 | 2019-2020 | |
| Sanara Medtech INC. | $81.63 | 2022 | |
| Puma Biotechnology, INC. | $80.82 | 2019-2020 | |
| Tesaro, INC. | $75.09 | 2019 | |
| Leica Microsystems INC. | $34.75 | 2019 | |
| Siemens Medical Solutions USA, INC. | $23.49 | 2025 | Acuson P500 Diagnostic Ultrasound System |
| Smith+Nephew, INC. | $21.55 | 2025 | Collagenase Santyl |
| Glaxosmithkline, LLC. | $21.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archit Naik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.